Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sweeney

Showing results (751-760 of 762) with videos related to

Pageof 77
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical developmentKim F McClure, Michael A Letavic, Amit S Kalgutkar, et al.
Journal of Neuro-Oncology|May 26, 2023
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivorsArchita Biswas, Manuela Salvucci, Kate Connor, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Nature Ecology & Evolution|June 11, 2021
Root traits explain plant species distributions along climatic gradients yet challenge the nature of ecological trade-offsDaniel C Laughlin, Liesje Mommer, Francesco Maria Sabatini, et al.
Cell|August 27, 2025
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancersEmily Grist, Peter Dutey-Magni, Marina A Parry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2015
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015S Gillessen, A Omlin, G Attard, et al.
Research Square|February 17, 2023
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trialMarina A Parry, Emily Grist, Larissa Mendes, et al.
Cancer Cytopathology|October 27, 2020
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countriesElena Vigliar, Rima Cepurnaite, Eduardo Alcaraz-Mateos, et al.
Cancer Cytopathology|January 10, 2022
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter studyElena Vigliar, Pasquale Pisapia, Filippo Dello Iacovo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2023
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
Pageof 77

Showing results (751-760 of 762) with videos related to

Sort By:
Pageof 77
Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical developmentKim F McClure, Michael A Letavic, Amit S Kalgutkar, et al.
Journal of Neuro-Oncology|May 26, 2023
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivorsArchita Biswas, Manuela Salvucci, Kate Connor, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Nature Ecology & Evolution|June 11, 2021
Root traits explain plant species distributions along climatic gradients yet challenge the nature of ecological trade-offsDaniel C Laughlin, Liesje Mommer, Francesco Maria Sabatini, et al.
Cell|August 27, 2025
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancersEmily Grist, Peter Dutey-Magni, Marina A Parry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2015
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015S Gillessen, A Omlin, G Attard, et al.
Research Square|February 17, 2023
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trialMarina A Parry, Emily Grist, Larissa Mendes, et al.
Cancer Cytopathology|October 27, 2020
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countriesElena Vigliar, Rima Cepurnaite, Eduardo Alcaraz-Mateos, et al.
Cancer Cytopathology|January 10, 2022
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter studyElena Vigliar, Pasquale Pisapia, Filippo Dello Iacovo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2023
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
Pageof 77